A new study suggests daily supplementation with Curcumin (Turmeric) might improve Body Mass Index (BMI), metabolic status and liver biomarkers in people with Non-Alcoholic Fatty Liver Disease (NAFLD).
87 people with grades 1-3 NAFLD (Non-Alcoholic Fatty Liver Disease) participated in this randomized controlled clinical study. The study lasted 8 weeks. Participants were assigned randomly to receive either a 1,000 mg daily dosage (divided into 2 doses) of Curcumin or a placebo. Researchers found a statistically significant reduction in BMI, .99 points in the group supplementing with Curcumin compared to .15 points in the group taking the placebo. Additionally waist circumference decreased by 1.74 for those taking the Curcumin compared to a reduction of .23 in the group supplementing with the placebo. Also, Ultrasonographic findings were improved in 75% of the participants in the Curcumin group compared to an improvement in 4.5% of the placebo group. Curcumin was also associated with a reduction in LDL cholesterol, total cholesterol, triglycerides, non-high density lipoprotein cholesterol and uric acid levels.
NAFLD is the most common type of chronic liver disorders and affects approximately 30% of the population and between 60 – 70% of individuals who have diabetes or who are obese.
Further studies are needed.
ASK US. WE KNOW. NOBODY KNOWS NUTRITION LIKE WE DO. NOBODY!
